ストックスクリーナーアプリを入手
41.74
0.00%
0.00
プレマーケット:
41.41
-0.33
-0.79%
前日終値:
$41.74
開ける：
$41.48
24時間の取引高:
571.25K
Relative Volume:
0.59
時価総額：
$3.37B
収益：
-
当期純損益:
$-64.16M
株価収益率:
-32.86
EPS:
-1.2702
ネットキャッシュフロー:
$-69.06M
1週間 パフォーマンス:
-2.04%
1か月 パフォーマンス:
+3.78%
6か月 パフォーマンス:
+51.89%
1年 パフォーマンス:
+23.86%
1日の値動き範囲:
$40.43
$42.36
1週間の範囲:
$40.43
$46.01
52週間の値動き範囲:
$14.80
$46.01
Cg Oncology Inc Stock (CGON) Company Profile
CGON を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CGON
Cg Oncology Inc
|
41.74 | 3.37B | 0 | -64.16M | -69.06M | -1.2702 |
|
VRTX
Vertex Pharmaceuticals Inc
|
444.64 | 110.88B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
726.21 | 72.79B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
890.11 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
404.46 | 54.85B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
189.85 | 41.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cg Oncology Inc Stock (CGON) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-24 | 開始されました | Truist | Buy |
| 2025-10-08 | 開始されました | Guggenheim | Buy |
| 2025-08-19 | 開始されました | Piper Sandler | Overweight |
| 2025-07-10 | 再開されました | Goldman | Buy |
| 2025-05-02 | 開始されました | JP Morgan | Overweight |
| 2025-04-16 | 開始されました | Scotiabank | Sector Perform |
| 2025-01-07 | 開始されました | TD Cowen | Buy |
| 2024-10-24 | 開始されました | UBS | Buy |
| 2024-09-23 | 開始されました | RBC Capital Mkts | Outperform |
| 2024-08-28 | 開始されました | ROTH MKM | Buy |
| 2024-06-28 | 開始されました | BofA Securities | Buy |
| 2024-02-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-02-20 | 開始されました | Goldman | Neutral |
| 2024-02-20 | 開始されました | Morgan Stanley | Overweight |
| 2024-02-14 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Cg Oncology Inc (CGON) 最新ニュース
How Positive Cretostimogene Trial Updates And Leadership Moves At CG Oncology (CGON) Have Changed Its Investment Story - Yahoo Finance
CG Oncology, Inc. (CGON) is a Buy on Cancer Treatment Development: Truist Securities - Insider Monkey
Promising Prospects for CG Oncology, Inc.: Buy Rating Backed by Cretostimogene’s Potential in NMIBC Market - TipRanks
CG Oncology (NASDAQ:CGON) Sets New 1-Year HighStill a Buy? - MarketBeat
Cg Oncology Inc. (CGON) Live Share Price, Invest From India - INDmoney
CG Oncology, Inc. (CGON) stock price, news, quote and history - Yahoo Finance UK
CG Oncology Incannounced topline data from Bond-003 cohort P and first results from Core-008 cohort A - marketscreener.com
New Cretostimogene Grenadenorepvec Data Highlight its Potential to Become the Backbone Therapy for High-Risk Non-Muscle Invasive Bladder Cancer - The Manila Times
CG Oncology Reports Promising Efficacy and Safety Data for Cretostimogene in High-Risk Non-Muscle Invasive Bladder Cancer Trials - Quiver Quantitative
CG Oncology (NASDAQ: CGON) posts 83.7% CR, no Grade 3+ AEs in NMIBC trial data - Stock Titan
Schroder Investment Management Group Acquires 155,737 Shares of CG Oncology, Inc. $CGON - MarketBeat
CG Oncology appoints Rossi to its Board of Directors - MSN
Muscle Invasive Bladder Cancer Market to Reach New Heights - openPR.com
Midday Stock Roundup: Tilly’s, indie Semiconductor Up - Orange County Business Journal
CG Oncology (CGON) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
FY2025 EPS Estimates for CG Oncology Increased by Analyst - MarketBeat
A Look at CG Oncology's (CGON) Valuation Following New Clinical Trial Data Announcements - Sahm
Will CG Oncology Inc. stock beat EPS estimatesMarket Sentiment Review & Proven Capital Preservation Tips - BỘ NỘI VỤ
Guidance Update: Will CG Oncology Inc. stock beat EPS estimates2025 Key Lessons & Proven Capital Preservation Tips - moha.gov.vn
Tejara Capital Ltd Purchases New Position in CG Oncology, Inc. $CGON - MarketBeat
Midday Stock Roundup: Eledon Up 4.8% - Orange County Business Journal
Intech Investment Management LLC Acquires 6,503 Shares of CG Oncology, Inc. $CGON - MarketBeat
CG Oncology, Inc. $CGON Shares Purchased by Franklin Resources Inc. - MarketBeat
Geode Capital Management LLC Increases Stake in CG Oncology, Inc. $CGON - MarketBeat
CG Oncology Appoints Christina Rossi to Board - MSN
Why analysts upgrade CG Oncology Inc. stock2025 Analyst Calls & Long-Term Growth Stock Strategies - moha.gov.vn
CG Oncology (NASDAQ:CGON) Reaches New 12-Month HighHere's What Happened - MarketBeat
[Form 4] CG Oncology, Inc. Insider Trading Activity - Stock Titan
[Form 3] CG Oncology, Inc. Initial Statement of Beneficial Ownership - Stock Titan
CG Oncology, Inc. Announces Board and Committee Changes - marketscreener.com
CG Oncology appoints Christina Rossi to board of directors By Investing.com - Investing.com Nigeria
Promising Developments in CG Oncology’s NMIBC Treatment Drive Buy Recommendation - TipRanks
CG Oncology appoints Christina Rossi to board as Simone Song resigns - Investing.com UK
CG Oncology appoints Christina Rossi to board as Simone Song resigns By Investing.com - Investing.com South Africa
CG Oncology appoints Christina Rossi to board of directors - Investing.com India
CG Oncology Announces Board Changes - TradingView
[8-K] CG Oncology, Inc. Reports Material Event | CGON SEC FilingForm 8-K - Stock Titan
CG Oncology Appoints Christina Rossi to Board of Directors - Quiver Quantitative
CG Oncology Announces New Board Member and Board Transition - The Manila Times
CG Oncology (NASDAQ: CGON) names Rossi to board amid BLA initiation - Stock Titan
CG Oncology, Inc. $CGON Position Lifted by Foresite Capital Management V LLC - MarketBeat
CG Oncology (NASDAQ: CGON) highlights BOND-003 and CORE-008 NMIBC data at SUO meeting - Stock Titan
Truist Financial Begins Coverage on CG Oncology (NASDAQ:CGON) - MarketBeat
CG Oncology, Inc. (CGON) Has a New Rating from Truist Financial - The Globe and Mail
CG Oncology Inc Stock Analysis and ForecastVolume Profile Analysis & Explosive Profit Growth - earlytimes.in
TD Cowen Initiates Coverage of CG Oncology (CGON) with Buy Recommendation - MSN
CG Oncology initiated with a Buy at Truist - TipRanks
Truist Securities initiates coverage on CG Oncology stock with Buy rating - Investing.com Canada
CG Oncology price target raised to $61 from $53 at RBC Capital - MSN
Ensign Peak Advisors Inc Has $10.31 Million Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
How Investors May Respond To CG Oncology (CGON) Leadership Transition Amid Rising Revenue and Expanding Losses - Sahm
Cg Oncology Inc (CGON) 財務データ
収益
当期純利益
現金流量
EPS
0.45%
0.12%
大文字化:
|
ボリューム (24 時間):